Dr. Ming's Chinese Capsule Recalled for Undeclared Sibutramine and Phenolphthalein
Slim Beauty USA is recalling Dr. Ming's Chinese Capsule because it contains undeclared sibutramine and phenolphthalein, making it an unapproved new drug.
The agency’s classification
FDA (Drugs): Class I
Class I is a situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 5/5 (Critical).
Highest-severity recall. The hazard can cause serious injury or death. Stop using the product now and follow the agency's instructions.
Our severity reasoning: The agency classification is FDA Class I, which mandates a severity score of 5 according to the rubric.
Plain-English summary
Slim Beauty USA is voluntarily recalling 4 bottles of Dr. Ming's Chinese Capsule, a 60-count dietary supplement distributed by Natural Products in Doral, Florida. The product is identified by Lot # 18 04 12 and an expiration date of 17 04 14.
The recall was initiated because the product contains undeclared sibutramine and phenolphthalein. These substances are not currently marketed in the United States, which classifies the product as an unapproved new drug marketed without an approved New Drug Application (NDA) or Abbreviated New Drug Application (ANDA).
Consumers who purchased this product should stop using it immediately and contact the recalling firm for further instructions. The product was distributed nationwide.
The recalled product
- Product
- Dr. Ming's Chinese Capsule (Ginger 50 mg, Camellia Sinensis 50 mg, Malus Domestica 50 mg, Propetary Blend 300 mg Cynara Scolymus, Hoodia, Siruline, Chitosan, 60-count bottles, Distributed by Natural Products, Doral, FL 33178.
- Manufacturer
- Slim Beauty USA
- Category
- Drug — Dietary Supplement
- Affected units
- 4
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: 18 04 12
- Exp 17 04 14
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 3 recalled by Slim Beauty USA under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 3 products in this recall →Related recalls
Same manufacturer · Slim Beauty USA
See all →- CriticalSlim Beauty USA Recalls Magic Slim Capsules Containing Unapproved Ingredients
FDA (Drugs) · 2014-04-16
- CriticalDream Body Slimming Capsule Recalled for Undeclared Sibutramine
FDA (Drugs) · 2014-04-16
Same hazard · undeclared ingredients
See all →- CriticalFDA Recalls Addall XR Shot Liquid Dietary Supplement
FDA (Food) · 2026-09-02
- SevereD'Dioses Mango Ice Pops Recalled for Undeclared Allergens
FDA (Food) · 2026-07-22
- ModerateSuper ProTHIN Plus Dietary Supplement Recalled for Undeclared Dyes
FDA (Food) · 2025-07-02
- LowGaiser's Recalls Ready-to-Eat Bologna Due to Undeclared Meat Ingredients
USDA FSIS · 2025-06-27
- HighFlour tortillas recalled due to undeclared wheat allergen
FDA (Food) · 2024-05-29
Similar recalls
- CriticalZI XIU TANG Beauty Capsules Recalled for Undeclared Sibutramine
FDA (Drugs) · 2016-07-13
- CriticalBotanicalNow BodySlim Herbal Capsules Recalled for Undeclared Sibutramine
FDA (Drugs) · 2018-01-31
- CriticalMiracle Diet 30 Recalled for Undeclared Phenolphthalein
FDA (Drugs) · 2015-11-18
- CriticalSuper Herbs 350 mg capsules recalled for undeclared active ingredients
FDA (Drugs) · 2016-06-01
- CriticalFit Firm and Fabulous Recalls Ultimate Herbal Slimcap Capsules
FDA (Drugs) · 2016-02-24
- CriticalDolphin Intertrade Recalls XIYOUJI QINGZHI CAPSULES Due to Undeclared Sibutramine
FDA (Drugs) · 2014-04-30